Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers

BACKGROUND: Tobacco use during pregnancy is the most important modifiable risk factor associated with adverse pregnancy outcomes, increasing the risk of preterm birth, intrauterine growth restriction and sudden infant death syndrome. Fewer than half of pregnant smokers can quit on their own. Identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Murff, Harvey J., Greevy, Robert A., Sanghani, Reesha S., Hartmann, Katherine E., Hartert, Tina V., Graves, Cornelia R., Lee, Scott S., Tindle, Hilary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669400/
https://www.ncbi.nlm.nih.gov/pubmed/34906201
http://dx.doi.org/10.1186/s13063-021-05865-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669400/
https://www.ncbi.nlm.nih.gov/pubmed/34906201
http://dx.doi.org/10.1186/s13063-021-05865-7

Ejemplares similares